Abstract
The history of multidisciplinary tumor boards extends to more than 50 years ago. At JADPRO Live Virtual 2021, presenters discussed the evidence-based impact of tumor boards on patient outcomes and patient-centered care, reviewed benefits and limitations of multidisciplinary tumor boards, and explained the potential role of advanced practitioners in tumor boards in a variety of oncology practice types.
